Association of serum γ-glutamyltransferase level and incident prehypertension in Korean men

Journal of Korean Medical Science

Volumn 28, Issue 11, 2013, Pages 1603-1608

  Chun, Hyejin ^a   Park, Sung Keun ^b   Ryoo, Jae Hong ^c,d  

^a Mokdong Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Bucheon Hospital   (South Korea)

Author keywords

Blood pressure; Gamma glutamyltransferase, prehypertension

Indexed keywords

BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; GAMMA-GLUTAMYLTRANSFERASE, PREHYPERTENSION; HUMAN; HYPERTENSION; INCIDENCE; MALE; OXIDATIVE STRESS; PREHYPERTENSION; PROSPECTIVE STUDY; SOUTH KOREA;

BLOOD PRESSURE; GAMMA-GLUTAMYLTRANSFERASE, PREHYPERTENSION;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; COHORT STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INCIDENCE; MALE; OXIDATIVE STRESS; PREHYPERTENSION; PROSPECTIVE STUDIES; REPUBLIC OF KOREA;

EID: 84904230429     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.11.1603     Document Type: Article

References (26)

1. Whitfield JB. Gamma glutamyltransferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
2. Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A. Gamma-glutamyltranspeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med 1997; 22: 853-60.
3. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535-9.
4. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, Tuomilehto J. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006; 27: 2170-6.
5. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007; 27: 127-33.
6. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358-66.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
8. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, Howard BV, Devereux RB. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009; 54: 974-80.
9. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-6.
10. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47: 410-4.
11. Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Ikai E, Yamaya H. Alcohol, high blood pressure, and serum gamma-glutamyltranspeptidase level. Hypertension 1991; 18: 819-26.
12. Nilssen O, Førde OH, Brenn T. The Tromsø Study: distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132: 318-26.
13. Shankar A, Li J. Association between serum gamma-glutamyltransferase level and prehypertension among US adults. Circ J 2007; 71: 1567-72.
14. Kawamoto R, Kohara K, Tabara Y, Kusunoki T, Otsuka N, Miki T. Association between serum gamma-glutamyltransferase level and prehypertension among community-dwelling men. Tohoku J Exp Med 2008; 216: 213-21.
15. Karakurt O, Cagirici G, Eryasar NE. Gamma-glutamyltransferase activity increases in prehypertensive patients. Turk J Med Sci 2011; 41: 975-80.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
17. Skurtveit S, Tverdal A. Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties. Drug Alcohol Depend 2002; 67: 95-8.
18. Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants: 'ATS-SARDEGNA' Research Group. Eur J Epidemiol 1996; 12: 71-6.
19. Lazo M, Selvin E, Clark JM. Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med 2008; 148: 348-52.
20. Miura K, Nakagawa H, Nakamura H, Tabata M, Nagase H, Yoshida M, Kawano S. Serum gamma-glutamyltransferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8: 445-9.
21. Zhang H, Thijs L, Kuznetsova T, Fagard RH, Li X, Staessen JA. Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes. J Hypertens 2006; 24: 1719-27.
22. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882-8.
23. Winegarden CR. From "prehypertension" to hypertension? additional evidence. Ann Epidemiol 2005; 15: 720-5.
24. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003; 333: 19-39.
25. Haynes WG, Morgan DA, Walsh SA, Sivitz WI, Mark AL. Cardiovascular consequences of obesity: role of leptin. Clin Exp Pharmacol Physiol 1998; 25: 65-9.
26. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005; 178: 327-30.